BCD Travel has launched a service and consulting platform designed specifically for the travel management giant’s life sciences clients. The new Life Sciences Center of Excellence was modeled after BCD Meetings & Events’ existing program of the same name and, like its M&E counterpart, is targeted at fulfilling the “unique and complex program needs” of pharmaceutical companies and other life sciences providers, BCD Travel said.
Those complexities—which include regulatory and compliance requirements and patient-centricity—have been exacerbated by the ongoing Covid-19 pandemic, BCD noted. Unlike the majority of corporate travel, life sciences providers not only have continued to travel amid the pandemic, but also have needed to extend support service to frontline workers, the TMC noted.
To help clients meet those challenges, the Life Sciences Center of Excellence will provide strategic consultation and best practices services. Areas of focus include balancing traveler experience with compliance and regulatory requirements, identifying value drivers unique to life sciences companies and providing holistic solutions across travel, M&E and patient engagement.
And with the increased prominence of clinical trials amid the pandemic driving many of BCD’s life sciences clients to seek support in serving the travel needs of trial patients, the TMC said it will “soon announce” enhanced service capabilities designed to meet that demand.
BCD Travel serves more than 100 corporate life sciences clients across more than 40 therapeutic areas, according to the company.